PNC-27 10 mg – 10 Vials

PNC-27 is a research peptide composed of a p53–MDM2 binding domain linked to a membrane-targeting sequence (residues 12–26 of the p53 protein). It has been shown in preclinical studies to interact with cancer cell membranes through HDM-2–associated mechanisms, leading to selective pore formation and membrane destabilization. PNC-27 is utilized in experimental oncology research to investigate peptide–membrane interactions, apoptotic signaling, and tumor-selective cytolytic activity in vitro